Antioxidant Intervention Attenuates Myocardial Neovascularization in Hypercholesterolemia

Background—Hypercholesterolemia (HC) and atherosclerosis can elicit oxidative stress, coronary endothelial dysfunction, and myocardial ischemia, which may induce growth-factor expression and lead to myocardial neovascularization. We tested the hypothesis that chronic antioxidant intervention in HC would attenuate neovascularization and preserve the expression of hypoxia-inducible factor (HIF)-1&agr; and vascular endothelial growth factor (VEGF). Methods and Results—Three groups of pigs (n= 6 each) were studied after 12 weeks of normal or 2% HC diet or HC+ antioxidant supplementation (100 IU/kg vitamin E and 1 g vitamin C daily). Myocardial samples were scanned ex vivo with a novel 3D micro-CT scanner, and the spatial density and tortuosity of myocardial microvessels were determined in situ. VEGF mRNA, protein levels of VEGF and VEGF receptor-1, HIF-1&agr;, nitrotyrosine, and superoxide dismutase (SOD) were determined in myocardial tissue. The HC and HC+ antioxidant groups had similar increases in serum cholesterol levels. HC animals showed an increase in subendocardial spatial density of microvessels compared with normal (160.5± 11.8 versus 95.3± 8.2 vessels/cm2, P < 0.05), which was normalized in HC+ antioxidant (92.5± 20.5 vessels/cm2, P < 0.05 versus HC), as was arteriolar tortuosity. In addition, HC induced upregulation of VEGF, HIF-1&agr;, and nitrotyrosine expression and decreased SOD expression and activity, all of which were preserved by antioxidant intervention. Conclusions—Changes in myocardial microvascular architecture invoked by HC are accompanied by increases in HIF-1&agr; and VEGF expression and attenuated by antioxidant intervention. This underscores a role of increased oxidative stress in modulating myocardial microvascular architecture in early atherogenesis.

[1]  G. Hutchins,et al.  Tortuosity as an index of the age and diameter increase of coronary collateral vessels in patients after acute myocardial infarction. , 1978, The American journal of cardiology.

[2]  E. Voest,et al.  Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. , 1996, The Journal of clinical investigation.

[3]  N. Maulik,et al.  Redox signaling in vascular angiogenesis. , 2002, Free radical biology & medicine.

[4]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[5]  A. Kawada,et al.  In vitro degradation of tropoelastin by reactive oxygen species , 1998, Archives of Dermatological Research.

[6]  K Walsh,et al.  Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. , 1998, Circulation.

[7]  M. Miyagi,et al.  Evidence That Light Modulates Protein Nitration in Rat Retina * , 2002, Molecular & Cellular Proteomics.

[8]  C. Napoli,et al.  Chronic antioxidant supplementation attenuates nuclear factor-kappa B activation and preserves endothelial function in hypercholesterolemic pigs. , 2002, Cardiovascular research.

[9]  N. Pumford,et al.  Western blot analysis for nitrotyrosine protein adducts in livers of saline-treated and acetaminophen-treated mice. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[10]  H. Lakka,et al.  Six-Year Effect of Combined Vitamin C and E Supplementation on Atherosclerotic Progression: The Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study , 2003, Circulation.

[11]  E L Ritman,et al.  Coronary microvascular functional reserve: quantification of long-term changes with electron-beam CT preliminary results in a porcine model. , 2001, Radiology.

[12]  L. Lerman,et al.  Vascular responses in vivo to 8-epiPGF2α in normal and hypercholesterolemic pigs , 2002 .

[13]  J. Thompson,et al.  Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  H. Pinedo,et al.  Induction of Vascular Endothelial Growth Factor Expression and Hypoxia-inducible Factor 1α Protein by the Oxidative Stressor Arsenite* , 2001, The Journal of Biological Chemistry.

[15]  T. V. van Berkel,et al.  Aorta of ApoE-Deficient Mice Responds to Atherogenic Stimuli by a Prelesional Increase and Subsequent Decrease in the Expression of Antioxidant Enzymes , 2003, Circulation research.

[16]  C. Napoli,et al.  Hypercholesterolemia impairs myocardial perfusion and permeability: role of oxidative stress and endogenous scavenging activity. , 2001, Journal of the American College of Cardiology.

[17]  C. Napoli,et al.  Involvement of oxidation-sensitive mechanisms in the cardiovascular effects of hypercholesterolemia. , 2001, Mayo Clinic proceedings.

[18]  S M Jorgensen,et al.  Three-dimensional imaging of vasculature and parenchyma in intact rodent organs with X-ray micro-CT. , 1998, The American journal of physiology.

[19]  E L Ritman,et al.  Altered Myocardial Microvascular 3D Architecture in Experimental Hypercholesterolemia , 2000, Circulation.

[20]  R. Kinscherf,et al.  Hypercholesterolemia increases manganese superoxide dismutase immunoreactive macrophages in myocardium , 1995, Histochemistry and Cell Biology.

[21]  S. Cheung,et al.  Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma. , 2003, Cancer research.

[22]  E. Ritman,et al.  Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia. , 2001, Cardiovascular research.

[23]  T. Galeotti,et al.  Reactive Oxygen Species as Downstream Mediators of Angiogenic Signaling by Vascular Endothelial Growth Factor Receptor-2/KDR* , 2002, The Journal of Biological Chemistry.

[24]  Laura I. Pelaez,et al.  Enhanced renal cortical vascularization in experimental hypercholesterolemia. , 2002, Kidney international.

[25]  L. Lerman,et al.  Vascular responses in vivo to 8-epi PGF(2alpha) in normal and hypercholesterolemic pigs. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[26]  L. Lerman,et al.  Simvastatin Preserves Coronary Endothelial Function in Hypercholesterolemia in the Absence of Lipid Lowering , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[27]  R. Busse,et al.  Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. , 1999, Diabetes.

[28]  C. Napoli,et al.  Hypertension exacerbates the effect of hypercholesterolemia on the myocardial microvasculature. , 2003, Cardiovascular research.

[29]  B. Ohlsson,et al.  Post‐transcriptional regulation of VEGF expression by oxidised LDL in human macrophages , 2002, European journal of clinical investigation.

[30]  M. Shibuya Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. , 2001, Cell structure and function.

[31]  K. Prasad,et al.  Time course study of oxidative stress in aorta and heart of diabetic rat. , 1996, Clinical science.

[32]  N. Chandel,et al.  Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Brown,et al.  A Randomised Controlled Trial of Vitamin E in Patients with Coronary Disease: The Cambridge Heart Antioxidant Study (CHAOS) , 1996 .

[34]  L. Brown,et al.  VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. , 1996, The American journal of physiology.

[35]  M. Bendeck Mining the myocardium with macrophage drills: A novel mechanism for revascularization. , 2000, Circulation research.

[36]  L. Szweda,et al.  Reactive nitrogen intermediates in giant cell arteritis: selective nitration of neocapillaries. , 2002, The American journal of pathology.

[37]  P. Libby,et al.  Neutrophil Elastase in Human Atherosclerotic Plaques: Production by Macrophages , 2003, Circulation.

[38]  Xianglin Shi,et al.  Vanadate-induced Expression of Hypoxia-inducible Factor 1α and Vascular Endothelial Growth Factor through Phosphatidylinositol 3-Kinase/Akt Pathway and Reactive Oxygen Species* , 2002, The Journal of Biological Chemistry.

[39]  J. Thompson,et al.  Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues. , 1998, Biochemistry.

[40]  S. Yusuf,et al.  Vitamin E supplementation and cardiovascular events in high-risk patients. , 2000, The New England journal of medicine.

[41]  N. Chandel,et al.  Reactive Oxygen Species Generated at Mitochondrial Complex III Stabilize Hypoxia-inducible Factor-1α during Hypoxia , 2000, The Journal of Biological Chemistry.

[42]  C. Heeschen,et al.  Statins Have Biphasic Effects on Angiogenesis , 2002, Circulation.